Page last updated: 2024-11-02

4-phenylbutyric acid and Arteriovenous Malformations

4-phenylbutyric acid has been researched along with Arteriovenous Malformations in 1 studies

4-phenylbutyric acid: RN refers to the parent cpd
4-phenylbutyric acid : A monocarboxylic acid the structure of which is that of butyric acid substituted with a phenyl group at C-4. It is a histone deacetylase inhibitor that displays anticancer activity. It inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells. It also inhibits protein isoprenylation, depletes plasma glutamine, increases production of foetal haemoglobin through transcriptional activation of the gamma-globin gene and affects hPPARgamma activation.

Arteriovenous Malformations: Abnormal formation of blood vessels that shunt arterial blood directly into veins without passing through the CAPILLARIES. They usually are crooked, dilated, and with thick vessel walls. A common type is the congenital arteriovenous fistula. The lack of blood flow and oxygen in the capillaries can lead to tissue damage in the affected areas.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, D1
Teng, JM1
North, PE1
Lapinski, PE1
King, PD1

Other Studies

1 other study available for 4-phenylbutyric acid and Arteriovenous Malformations

ArticleYear
RASA1-dependent cellular export of collagen IV controls blood and lymphatic vascular development.
    The Journal of clinical investigation, 2019, 06-11, Volume: 129, Issue:9

    Topics: Animals; Animals, Newborn; Apoptosis; Arteriovenous Malformations; Cell Line, Tumor; Collagen Type I

2019